InnoCan Pharma

InnoCan Pharma stands at the forefront of pharmaceutical innovation, dedicated to enhancing quality of life through the development of novel therapeutics. Specializing in harnessing the unique healing properties of Cannabinoids, InnoCan Pharma is committed to creating powerful, patent-pending formulas that set new standards in patient care. Located at 10 Hamenofim St., Herzliya, Israel 4672561, IL, InnoCan Pharma is strategically positioned to leverage Israel’s world-leading medical cannabis research community.

With a focus on dermatology treatment design, InnoCan Pharma is initially targeting the multi-billion dollar markets of psoriasis and localized pain, where research indicates that topical cannabinoid-combined treatments are highly effective. Furthermore, InnoCan Pharma is expanding its reach into oral hygiene, eczema/itching, skin support after chemotherapy, and women's health, addressing a broad spectrum of healthcare needs. The company's commitment to innovation ensures that its products are highly differentiated, combining the synergistic effects of Cannabis-complex Hemp Oil with active ingredients and advanced on-demand release delivery systems.

InnoCan Pharma is dedicated to bringing outstanding new products to market that combine the therapeutic potential of Cannabinoid complex/hemp oil with existing approved OTC drugs. We invite the manager of InnoCan Pharma to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work. This detailed showcase will provide an opportunity to connect with a wider audience and drive commercial development.